Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Profiteer who wrote (1870)	6/26/1998 3:03:00 PM
From: Hyrulean King	Read Replies (2) \| Respond to of 5402

This makes sense; according to business plan they want a strategic alliance w/ a large pharmaceutical firm within the next 3 years i believe - or was that 6 months? I left the literature at home.... chief where's the beef

To: Profiteer who wrote (1870)	6/26/1998 3:18:00 PM
From: Andrew H	Read Replies (3) \| Respond to of 5402

>>Sanguine Corp. will only be seeking FDA approval of Pher-02's use in one or two application. It has approximately 150 uses in all. After the first FDA approval is granted, doctors will be given permission by Sanguine to use Pher-02 in other blood related procedures with the understanding they collect data results and resubmit them back to the company. << Any idea which applications those might be--it makes a HUGE difference in terms of the market. >>After the first FDA approval is granted<< It would be far more accurate to say, "if and when FDA approval is granted,..." I don't know about substances used in surgical procedures, but as far as drugs go, the FDA has little to say about off label prescription--it is up to the individual doctors. In any case, I suspect that it would not be up to SGNC to give doctors permission to use Pher-02 for off unapproved procedures. That would most likely be up to the FDA or the individual doctors. Certainly the FDA would need to approve experimental use of PHER-02 in non-approved procedures.